Meixiu Jiang

834 total citations
40 papers, 616 citations indexed

About

Meixiu Jiang is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Meixiu Jiang has authored 40 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Immunology and 10 papers in Surgery. Recurrent topics in Meixiu Jiang's work include Cholesterol and Lipid Metabolism (7 papers), interferon and immune responses (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Meixiu Jiang is often cited by papers focused on Cholesterol and Lipid Metabolism (7 papers), interferon and immune responses (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Meixiu Jiang collaborates with scholars based in China and United States. Meixiu Jiang's co-authors include Yuanli Chen, Yajun Duan, Xiaoju Li, Jihong Han, Mingui Fu, Hong‐Bo Xin, Xiaoxiao Yang, Ke‐Yu Deng, Pengzhi Dong and Xiaolei Wang and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Biochemical Journal.

In The Last Decade

Meixiu Jiang

36 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meixiu Jiang China 16 257 191 142 90 89 40 616
Yonghae Son South Korea 14 294 1.1× 202 1.1× 177 1.2× 63 0.7× 76 0.9× 40 601
Yuzhen Zhuo China 17 385 1.5× 216 1.1× 161 1.1× 109 1.2× 77 0.9× 46 793
Ting Jiang China 13 271 1.1× 81 0.4× 112 0.8× 94 1.0× 84 0.9× 30 673
Shanshan Wu China 17 283 1.1× 158 0.8× 54 0.4× 58 0.6× 70 0.8× 31 714
Varvara A. Orekhova Russia 13 337 1.3× 250 1.3× 97 0.7× 89 1.0× 96 1.1× 32 791
Xuguang Hu China 15 379 1.5× 90 0.5× 156 1.1× 78 0.9× 163 1.8× 48 814
Ran Xue China 16 258 1.0× 82 0.4× 150 1.1× 171 1.9× 85 1.0× 35 697
Rodolphe Filomenko France 16 493 1.9× 166 0.9× 117 0.8× 79 0.9× 112 1.3× 18 809
Jingmei Song China 11 202 0.8× 93 0.5× 216 1.5× 93 1.0× 73 0.8× 22 540

Countries citing papers authored by Meixiu Jiang

Since Specialization
Citations

This map shows the geographic impact of Meixiu Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meixiu Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meixiu Jiang more than expected).

Fields of papers citing papers by Meixiu Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meixiu Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meixiu Jiang. The network helps show where Meixiu Jiang may publish in the future.

Co-authorship network of co-authors of Meixiu Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Meixiu Jiang. A scholar is included among the top collaborators of Meixiu Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meixiu Jiang. Meixiu Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yan-Chun, Lixing Li, Jiaqing Xiang, et al.. (2025). TRIM65 as a key regulator of ferroptosis and glycolysis in lactate-driven renal tubular injury and diabetic kidney disease. Cell Reports. 44(8). 116091–116091. 2 indexed citations
2.
Chen, Liang, et al.. (2025). The advancement of targeted regulation of hepatic stellate cells using traditional Chinese medicine for the treatment of liver fibrosis. Journal of Ethnopharmacology. 341. 119298–119298. 5 indexed citations
3.
4.
5.
Lai, Yuping, et al.. (2025). An update on the role and mechanisms of periodontitis in cardiovascular diseases. Cellular Signalling. 132. 111770–111770. 2 indexed citations
6.
Yang, Yuting, Ting Long, Xiaoxue Wang, et al.. (2025). Hyperhomocysteinaemia aggravates periodontitis by suppressing the Nrf2/HO-1 signalling pathway. Redox Report. 30(1). 2475691–2475691. 2 indexed citations
7.
Jiang, Meixiu, Dan Wang, Ning Su, et al.. (2024). TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway. International Immunopharmacology. 128. 111494–111494. 15 indexed citations
8.
Wei, Xiaoning, Mengmeng Zhu, Mengyuan Fang, et al.. (2023). The pterostilbene-dihydropyrazole derivative Ptd-1 ameliorates vascular calcification by regulating inflammation. International Immunopharmacology. 125(Pt B). 111198–111198. 6 indexed citations
9.
Zhu, Mengmeng, Shengnan Wang, Tingting Zhang, et al.. (2023). Transcription factor 21 accelerates vascular calcification in mice by activating the IL-6/STAT3 signaling pathway and the interplay between VSMCs and ECs. Acta Pharmacologica Sinica. 44(8). 1625–1636. 20 indexed citations
10.
Jiang, Meixiu, et al.. (2022). Identification and Verification of Potential Core Genes in Pediatric SepticShock. Combinatorial Chemistry & High Throughput Screening. 25(13). 2228–2239. 4 indexed citations
11.
Qian, Yisong, Ziwei Wang, Li Zuo, et al.. (2018). CD38 Deficiency Promotes Inflammatory Response through Activating Sirt1/NF-κB-Mediated Inhibition of TLR2 Expression in Macrophages. Mediators of Inflammation. 2018. 1–13. 23 indexed citations
12.
Jiang, Meixiu, Xuan Hong, Shuizhen Shi, et al.. (2017). Expression profiling of TRIM protein family in THP1-derived macrophages following TLR stimulation. Scientific Reports. 7(1). 42781–42781. 55 indexed citations
13.
Dong, Pengzhi, Lanlan Pan, Xiting Zhang, et al.. (2017). Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice. Journal of Ethnopharmacology. 198. 479–488. 51 indexed citations
14.
Jiang, Meixiu, Chunling Jiang, Mingui Fu, et al.. (2016). Evaluation of the Antioxidative, Antibacterial, and Anti-Inflammatory Effects of theAloeFermentation Supernatant ContainingLactobacillus plantarumHM218749.1. Mediators of Inflammation. 2016. 1–8. 32 indexed citations
15.
Wang, Xin, Xiao Hu, Xigao Cheng, et al.. (2016). High-throughput sequencing of microbial diversity in implant-associated infection. Infection Genetics and Evolution. 43. 307–311. 6 indexed citations
16.
Jiang, Meixiu & Xiaoju Li. (2016). Activation of PPARγ does not contribute to macrophage ABCA1 expression and ABCA1-mediated cholesterol efflux to apoAI. Biochemical and Biophysical Research Communications. 482(4). 849–856. 15 indexed citations
17.
Yu, Miao, Meixiu Jiang, Yuanli Chen, et al.. (2016). Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen. Journal of Biological Chemistry. 291(33). 16977–16989. 61 indexed citations
18.
Zhang, Ling, Meixiu Jiang, Yuanli Chen, et al.. (2013). DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux—An LXR-dependent mechanism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(6). 1134–1145. 20 indexed citations
19.
Chen, Yuanli, Yajun Duan, Xiaoxiao Yang, et al.. (2012). Activation of Liver X Receptor Induces Macrophage Interleukin-5 Expression. Journal of Biological Chemistry. 287(52). 43340–43350. 51 indexed citations
20.
Hu, Wenquan, Xiaoye Zhou, Meixiu Jiang, et al.. (2012). Statins synergize dexamethasone-induced adipocyte fatty acid binding protein expression in macrophages. Atherosclerosis. 222(2). 434–443. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yonghae Son Breakdown of academic impact, for papers by Yuzhen Zhuo Breakdown of academic impact, for papers by Ting Jiang Breakdown of academic impact, for papers by Shanshan Wu Breakdown of academic impact, for papers by Varvara A. Orekhova Breakdown of academic impact, for papers by Xuguang Hu Breakdown of academic impact, for papers by Ran Xue Breakdown of academic impact, for papers by Rodolphe Filomenko Breakdown of academic impact, for papers by Jingmei Song
Rankless by CCL
2026